According to RxSight's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 21.9115. At the end of 2023 the company had a P/S ratio of 16.2.
Year | P/S ratio | Change |
---|---|---|
2023 | 16.2 | 126.48% |
2022 | 7.17 | -47.38% |
2021 | 13.6 |